The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer<i>in vivo</i>
Frank P. Vendetti(University of Pittsburgh), Christopher J. Bakkenist(UPMC Hillman Cancer Center)
Cited by 240
Related Papers
ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1
|Nature Communications|2017|104
Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation
|Scientific Reports|2017|20
A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX phosphorylation in human peripheral blood mononuclear cells
|Oncoscience|2015|18
Radiation therapy induces the DNA damage response in peripheral blood
|Oncotarget|2013|16